Literature DB >> 20854325

Rheumatic fever in indigenous Australian children.

Matthew G Parnaby1, Jonathan R Carapetis.   

Abstract

Rheumatic heart disease (RHD) caused by acute rheumatic fever (ARF) is a disease of poverty, poor hygiene and poor living standards. RHD remains one of the major causes of childhood cardiac disease in developing nations. Within developed nations, there has been a dramatic drop in the prevalence of RHD because of the improvement of living standards, access to health care and the widespread availability of penicillin-based drugs. Despite a dramatic reduction of RHD in Australia overall, it continues to be a major contributor to childhood and adult cardiac disease in Indigenous communities throughout northern and central Australia. Currently, Australia has among the highest recorded rates of ARF and RHD in the world. The most accurate epidemiological data in Australia come from the Northern Territory's RHD control programme. In the Northern Territory, 92% of people with RHD are Indigenous, of whom 85% live in remote communities and towns. The incidence of ARF is highest in 5-14-year-olds, ranging from 150 to 380 per 100,000. Prevalence rates of RHD since 2000 have steadily increased to almost 2% of the Indigenous population in the Northern Territory, 3.2% in those aged 35-44 years. Living in remote communities is a contributing factor to ARF/RHD as well as a major barrier for adequate follow-up and care. Impediments to ARF/RHD control include the paucity of specialist services, rapid turnover of health staff, lack of knowledge of ARF/RHD by health staff, patients and communities, and the high mobility of the Indigenous population. Fortunately, the recently announced National Rheumatic Fever Strategy, comprising recurrent funding to the Northern Territory, Queensland and Western Australia for control programmes, as well as the creation of a National Coordination Unit suggest that RHD control in Australia is now a tangible prospect. For the disease to be eradicated, Australia will have to address the underpinning determinants of poverty, social and living conditions.
© 2010 The Authors. Journal of Paediatrics and Child Health © 2010 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Mesh:

Year:  2010        PMID: 20854325     DOI: 10.1111/j.1440-1754.2010.01841.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  34 in total

1.  Acute rheumatic fever in First Nations communities in northwestern Ontario: Social determinants of health "bite the heart".

Authors:  Janet Gordon; Mike Kirlew; Yoko Schreiber; Raphael Saginur; Natalie Bocking; Brittany Blakelock; Michelle Haavaldsrud; Christine Kennedy; Terri Farrell; Lloyd Douglas; Len Kelly
Journal:  Can Fam Physician       Date:  2015-10       Impact factor: 3.275

Review 2.  Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity.

Authors:  Soumya D Chakravarty; John B Zabriskie; Allan Gibofsky
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

3.  HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children.

Authors:  Rebecca A Porritt; Lisa Paschold; Magali Noval Rivas; Mary Hongying Cheng; Lael M Yonker; Harsha Chandnani; Merrick Lopez; Donjete Simnica; Christoph Schultheiß; Chintda Santiskulvong; Jennifer Van Eyk; John K McCormick; Alessio Fasano; Ivet Bahar; Mascha Binder; Moshe Arditi
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

4.  The control of rheumatic fever and rheumatic heart disease: a call to raise the awareness.

Authors:  Sirageldin M Kheir; Sulafa Khalid M Ali
Journal:  Sudan J Paediatr       Date:  2014

Review 5.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

Review 6.  Antibiotic prescribing for upper respiratory tract infections in the Asia-Pacific region: A brief review.

Authors:  C L Teng
Journal:  Malays Fam Physician       Date:  2014-08-31

Review 7.  Screening for rheumatic heart disease: current approaches and controversies.

Authors:  Kathryn Roberts; Samantha Colquhoun; Andrew Steer; Bo Reményi; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-11-13       Impact factor: 32.419

Review 8.  Cutting edge issues in rheumatic fever.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

9.  Cardiac myosin epitopes for monitoring progression of rheumatic fever.

Authors:  Davina E Gorton; Brenda L Govan; Natkunam Ketheesan; Alan A Sive; Robert E Norton; Bart J Currie; Rebecca J Towers; Adita I Mascaro-Blanco; Madeleine W Cunningham
Journal:  Pediatr Infect Dis J       Date:  2011-11       Impact factor: 2.129

10.  Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage.

Authors:  Mark E Engel; Babu Muhamed; Andrew C Whitelaw; Munyaradzi Musvosvi; Bongani M Mayosi; James B Dale
Journal:  Pediatr Infect Dis J       Date:  2014-02       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.